Elutia Inc. Class A (ELUT) Dividend History

Elutia Inc. Class A (ELUT) is a healthcare company focused on developing innovative treatments and solutions in the field of specialty pharmaceuticals. The company emphasizes research and development to address unmet medical needs and improve patient outcomes.

12510 Prosperity Drive, Silver Spring, MD, 20904
Phone: 240-247-1143
Website: https://www.aziyo.com

Dividend History

Elutia Inc. Class A currently does not pay dividends

Company News

  • BRC, Costamare and Elutia have been highlighted in this Screen of The Week article.

    Zacks Investment Research
    Featured Companies: BRCC CMRE
  • SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded warrant. The gross proceeds to Elutia from the offering are expected to be approximately $13.26 million, before deducting placement agent fees and other offering expenses payable by Elutia. The offering is expected to close on or about June 18, 2024, subject to customary closing conditions.

    GlobeNewswire Inc.
  • Elutia (NASDAQ:ELUT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 2 0 0 0 3M Ago 0 0 0 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Elutia. The company has an average price ...Full story available on Benzinga.com

    Benzinga
Page data last updated 07/23/2025 22:47:56 UTC